Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PRME

Prime Medicine Inc

Apr 28 • 04:00PM ET

3.69

+0.02 0.54 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CRSP NTLA EDIT BEAM ALLO VERV DNLI IGMS PSTX SANA

| Held by: ARKG XBI VTI IWM VXF IWN IBB SCHA VTWO IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.37	Insider Own	47.66%	Shs Outstand	180.51M	Perf Week	-3.15%
Market Cap	666.24M	Forward P/E	-	EPS next Y	-0.85	Insider Trans	0.00%	Shs Float	94.50M	Perf Month	9.17%
Enterprise Value	604.99M	PEG	-	EPS next Q	-0.25	Inst Own	41.43%	Short Float	32.00%	Perf Quarter	-13.79%
Income	-201.14M	P/S	143.90	EPS this Y	30.16%	Inst Trans	5.21%	Short Ratio	12.00	Perf Half Y	-30.77%
Sales	4.63M	P/B	5.51	EPS next Y	9.74%	ROA	-36.35%	Short Interest	30.24M	Perf YTD	6.34%
Book/sh	0.67	P/C	3.75	EPS next 5Y	15.47%	ROE	-146.81%	52W High	6.94 -46.83%	Perf Year	122.29%
Cash/sh	0.98	P/FCF	-	EPS past 3/5Y	2.55% -91.28%	ROIC	-87.77%	52W Low	1.11 232.43%	Perf 3Y	-73.20%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -2.32%	Gross Margin	-58.05%	Volatility	6.12% 6.87%	Perf 5Y	-
Dividend TTM	-	EV/Sales	130.67	EPS Y/Y TTM	19.04%	Oper. Margin	-4498.06%	ATR (14)	0.25	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.84	Sales Y/Y TTM	55.28%	Profit Margin	-4342.44%	RSI (14)	50.18	Recom	1.55
Dividend Gr. 3/5Y	- -	Current Ratio	4.84	EPS Q/Q	28.39%	SMA20	1.64%	Beta	2.44	Target Price	7.16
Payout	-	Debt/Eq	0.96	Sales Q/Q	-61.61%	SMA50	-0.51%	Rel Volume	0.62	Prev Close	3.67
Employees	146	LT Debt/Eq	0.90	Earnings	Mar 03 BMO	SMA200	-9.51%	Avg Volume	2.52M	Price	3.69
IPO	Oct 20, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.54% -34.60%	Trades		Volume	1,571,740	Change	0.54%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)